clinical trials

THREAD Research CEO John Reites speaks on the state of remote and hybrid trials, and how COVID-19 has accelerated an already blossoming field.

COVID-19 has heightened public interest in vaccine and therapeutic research, and CCT President CJ Anderson says it's time to build on that engagement, finding new ways to enroll volunteers in other clinical trials and improve the patient experience.

Jennifer Price, THREAD's executive director of data and analytics, discusses using remote monitoring technology to expand the reach of clinical trials.

Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.

The company will expand its oncolytic viral therapy platform to combat cancer.

The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.

The capital raised will also increase its team of clinical trial experts in serving both pharma and patients across the UK and overseas.

The funding will also help get much-needed therapies to patients faster. 

Panelists at Women of Wearable's FemTech Forum discuss how big data and digital tools could help booster female representation in clinical trials. 

Sanofi execs Ruchita Sinha and Christina Koutoudis share the company’s thoughts about digital technology, innovation and pharma's role and future.